ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Fmoc-Trp(Boc)-Ser(Psi(Me,Me)pro)-OH
C37H39N3O8
653.7 g/mol
Research Reagent

Fmoc-Trp(Boc)-Ser(Psi(Me,Me)pro)-OH

CAS908601-15-0
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a peptide building block featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and a tert-butoxycarbonyl (Boc)-protected indole moiety, incorporated into an oxazolidine ring system. It is primarily used in solid-phase peptide synthesis for the construction of complex peptide sequences.

peptide synthesis building blockresearch reagent for solid-phase peptide synthesis

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Fmoc-Trp(Boc)-Ser(Psi(Me,Me)pro)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.76

Fmoc-Trp(Boc)-Thr(Psi(Me,Me)pro)-OH

CAS936707-21-0

pharmaceutical intermediate

ApplicationSame Use

N-Acetyl-L-prolinamide

CAS16395-58-7

research compound

ReferenceSame Category

4-Amino-7-methylindole

CAS90868-08-9

research compound

ReferenceSame Category

2-Chloro-3-iodopyridin-4-amine

CAS909036-46-0

research compound

ReferenceSame Category

Fmoc-Glu(OtBu)-Ser(Psi(Me,Me)pro)-OH

CAS909115-33-9

research compound

ReferenceSame Category

Methyl 5-(aminomethyl)-2-chlorobenzoate--hydrogen chloride (1/1)

CAS90942-47-5

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

3-[2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]propanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid

InChIKey

BVOXZEOINKCAMZ-UHFFFAOYSA-N

SMILES

CC1(N(C(CO1)C(=O)O)C(=O)C(CC2=CN(C3=CC=CC=C32)C(=O)OC(C)(C)C)NC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46)C

Synonyms (5)

—

Sourcing Fmoc-Trp(Boc)-Ser(Psi(Me,Me)pro)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→